Glenmede Trust’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Glenmede Trust’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-797	Closed	-$2K	–	2572
2020 Q3	$2K	Hold	797	–	–	﹤0.01%	2311
2020 Q2	$3K	Sell	797 -7,173	-90%	-$37.2K	﹤0.01%	2208
2020 Q1	$3K	Buy	7,970 +7,173	+900%	+$51.9K	﹤0.01%	2831
2019 Q4	$3K	Hold	797	–	–	﹤0.01%	2831
2019 Q3	$6K	Hold	797	–	–	﹤0.01%	2595
2019 Q2	$5K	Hold	797	–	–	﹤0.01%	2660
2019 Q1	$6K	Hold	797	–	–	﹤0.01%	2584
2018 Q4	$6K	Hold	797	–	–	﹤0.01%	2503
2018 Q3	$12K	Buy	+797	New	+$9.6K	﹤0.01%	1374
2018 Q2	–	Sell	-797	Closed	-$8K	–	2454
2018 Q1	$8K	Hold	797	–	–	﹤0.01%	2273
2017 Q4	$8K	Hold	797	–	–	﹤0.01%	2273
2017 Q3	$12K	Hold	797	–	–	﹤0.01%	2139
2017 Q2	$20K	Hold	797	–	–	﹤0.01%	1916
2017 Q1	$20K	Hold	797	–	–	﹤0.01%	1916
2016 Q4	$35K	Hold	797	–	–	﹤0.01%	1721
2016 Q3	$12K	Hold	797	–	–	﹤0.01%	2100
2016 Q2	$26K	Hold	797	–	–	﹤0.01%	1810
2016 Q1	$22K	Hold	797	–	–	﹤0.01%	1796
2015 Q4	$37K	Hold	797	–	–	﹤0.01%	1667
2015 Q3	$142K	Hold	797	–	–	﹤0.01%	1280
2015 Q2	$113K	Hold	797	–	–	﹤0.01%	1391
2015 Q1	$107K	Hold	797	–	–	﹤0.01%	1452
2014 Q4	$142K	Buy	797 +573	+256%	+$102K	﹤0.01%	1422
2014 Q3	$53K	Hold	224	–	–	﹤0.01%	1674
2014 Q2	$98K	Hold	224	–	–	﹤0.01%	1406
2014 Q1	$102K	Hold	224	–	–	﹤0.01%	1409
2013 Q4	$107K	Buy	224 +204	+1,020%	+$99.7K	﹤0.01%	1380
2013 Q3	$9K	Hold	20	–	–	﹤0.01%	1954
2013 Q2	$9K	Buy	+20	New	+$9.07K	﹤0.01%	1898

Other funds holding IDXG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Glenmede Trust's IDXG Position: Q4 2020 in Review

Glenmede Trust sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q4 2020, closing a stake of 797 shares — an estimated $2K sold.

Glenmede Trust first reported a position in IDXG in Q2 2013 and held it in 29 quarters. The position peaked at $142K in Q3 2015. 12 funds tracked by Wall St. Rank hold IDXG as of Q4 2020.

Glenmede Trust reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 797 Interpace Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $2K.
Glenmede Trust first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 29 quarters.
Glenmede Trust's Interpace Biosciences, Inc. Common Stock position peaked at $142K in Q3 2015.
12 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.